Rockville, MD, United States of America
Macrogenics, Inc.
Patents = 128
Trademarks = 7
Forward Citations = 2,190
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
79 inventors (with patents filed for the assignee):
MacroGenics is a biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics. With a unique and proprietary suite of antibody technologies, MacroGenics aims to create next-generation medicines that improve patients' lives. They have a diverse pipeline of product candidates in various stages of development for the treatment of cancer, autoimmune disorders, infectious diseases, and immunology disorders. For more information about MacroGenics, please visit their website.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com